What working capital loan options are available for medical spas?

Medical spa working capital needs are distinct from most personal-care businesses because the core product — injectables — must be purchased before the appointment, stored in compliance with cold-chain requirements (2–8°C for Botox and most biologics), and used within the product's shelf life or discarded. A busy med spa may spend $15,000–$50,000 per month on Botox, hyaluronic acid fillers (Juvederm, Restylane), Sculptra, Kybella, and other injectables — capital that must be on hand before a single appointment generates revenue. Layered on top is the payroll for licensed clinical staff (RNs, NPs, PAs, MDs) — the highest-cost labor category in aesthetics — plus skincare product inventory, marketing spend, and operating overhead. A revolving line of credit sized to cover 30–45 days of injectables inventory plus payroll smoothing is the standard working capital instrument for an established med spa.

How injectables inventory, membership models, and licensed-staff payroll affect working capital qualification

Lenders evaluate med spa working capital needs on three dimensions: (1) Injectables inventory cycle — Botox (onabotulinumtoxinA) and most dermal fillers are purchased from authorized distributors (Allergan/AbbVie, Galderma, Revance), invoiced on net-30 terms, and must be stored refrigerated; the time between purchase and revenue recognition is typically 7–21 days; lenders size the revolver based on average monthly injectables spend and typical payment terms. (2) Membership revenue predictability — practices with a membership model have more predictable ARR; lenders weight membership ARR more heavily than transactional service revenue when calculating eligible revolver draw amounts. (3) Licensed staff payroll density — a med spa employing NPs, PAs, and RNs carries significantly higher payroll per revenue dollar than a retail personal-care business; biweekly payroll cycles create a recurring cash flow gap between payroll disbursement and membership billing; lines sized to 4–6 weeks of payroll provide adequate coverage.

Working capital loan mechanics for medical spas

• Revolving line of credit — draw as needed, repay as revenue clears; $25,000–$500,000 range for established med spas; interest-only on outstanding balance; typical rate Federal Reserve prime + 2–6% depending on FICO and time in business
• SBA Working Capital CAPLine — revolving SBA-guaranteed line; funds injectables inventory, skincare products, and payroll; secured by accounts receivable and inventory; useful for practices with documented injectables purchase orders and membership ARR
• Short-term working capital term loan — 6–18-month term; $25,000–$250,000; for seasonal marketing pushes, hiring ramp for new NPs, or bridging a gap between device purchase and first revenue
• Revenue-based advance (MCA) — advance on card receipts; high card volume at cash-pay med spas supports larger approvals; repaid as daily percentage of card sales; highest cost but fastest to fund (24–72 hours)
• Injectables distributor credit terms — Allergan/AbbVie (Botox), Galderma (Dysport, Restylane), and Revance (Daxxify) offer net-30 to net-60 terms to established accounts; extending distributor terms reduces the working capital draw needed from a bank line

SBA program fit for med spa working capital

The SBA Working Capital CAPLine is a revolving SBA-guaranteed facility for businesses with documented short-term working capital needs — specifically suited to businesses like med spas that carry recurring inventory and payroll obligations against predictable revenue. CAPLines revolve against accounts receivable and inventory, providing a scalable facility that grows with the practice. Under 13 CFR Part 121, NAICS 812199 operators qualify for SBA programs at average annual receipts under $9.0M. For practices that don't need the full SBA infrastructure, conventional revolving lines process faster — but the SBA CAPLine provides the longest terms and lowest rates for qualifying operators.

Common qualification thresholds for med spa working capital loans

• Revolving line of credit (conventional): 620+ owner FICO, 12+ months operating, $15,000+ average monthly net deposits, active medical director, documented injectables inventory cycle
• SBA Working Capital CAPLine: 650+ FICO, 2+ years operating, 1.25x DSCR, documented AR and inventory eligible for revolving borrowing base, CPOM-compliant entity
• Short-term working capital term loan: 600+ FICO, 6+ months operating, $10,000+ average monthly deposits; 6–18-month repayment term
• Revenue-based advance: 550+ FICO, 6+ months operating, $15,000+ monthly card revenue; fastest to fund but highest cost
• Line sizing: lenders typically size working capital lines at 1–2 months of average monthly revenue or 10–15% of annual revenue; injectables-heavy practices with documented purchase schedules qualify for larger draws

Med-spa-specific working capital underwriting concerns

Working capital underwriters evaluate med spas on factors specific to medical aesthetics: (1) Injectables cold-chain documentation — lenders reviewing inventory as collateral require evidence of compliant refrigerated storage (2–8°C temperature logs); non-compliant storage of Botox or biologics makes the inventory worthless and invalidates inventory-based borrowing base calculations. (2) Authorized distributor relationships — Botox, Dysport, Juvederm, Restylane, and Sculptra must be purchased from FDA-authorized distributors; gray-market injectables are illegal and subject to FDA enforcement action and are not valid inventory collateral. (3) Membership billing cycle alignment — practices with monthly membership billing have predictable cash inflows that align with line repayment; lenders favor this predictability over purely transactional practices with lumpy revenue. (4) Seasonal working capital spikes — Q4 (November–December holiday gift card and treatment packages) and pre-summer body-contouring season (March–May) create predictable demand spikes; revolving lines should be drawn proactively before peak periods. (5) Medical director compensation in payroll — if the medical director is on payroll, their compensation is part of the working capital payroll calculation; practices should document medical director compensation clearly in financial statements.